digital therapeutics
DarioHealth's chief medical officer, Dr. Omar Manejwala, talks about how the company helps employers support employees with chronic conditions, the advancement of its platform after its Twill acquisition, and expanding its reach with Medicaid.
Aaron Blackmon and Joshua Mattson, DuploCloud account executives, discuss cybersecurity and how the company helps digital health and health tech companies with backend cloud infrastructure automation.
Sanofi head of organization capability and transformation, Felix Lee, discusses how the pharma giant leverages digital therapeutics company DarioHealth to complement its drug offerings and enhance patient care and self-management.
Michael Pace, founder and president of PalmHealthCo, highlights how his company advises organizations, including pharma, in commercialization and go-to-market strategies for digital therapeutics - and his experience at Pear Therapeutics.
Eversana senior vice president of health innovation, Alberta Spreafico, discusses the company's collaboration with the Digital Therapeutics Alliance to analyze frameworks and map reimbursement pathways in Europe for digital health adoption.
Digital therapeutics can improve health equity by empowering patients to adhere to medication intake, says Tanisha Hill, founder and president of the Digital Health for Equitable Health Alliance. Still, the digital divide needs to be addressed.
Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.
Dr. Dennis Truong, regional telemedicine/mobility director at Kaiser Permanente, highlights the challenges of implementing digital therapeutics in the care system and its ultimate value in improving patients' and providers’ care journeys.
Andy Molnar, CEO of the Digital Therapeutics Alliance, and Scott Stuewe, president and CEO of DirectTrust, discuss their partnership to show digital therapeutics' value and accreditation in healthcare for payors considering DTx coverage.